Related Experiment Videos
Update on the use of cefotaxime for pediatric meningitis in Portugal
H Lecour1, A M Miranda, J A Nogueira
1Service of Infectious Diseases, School of Medicine, Hospital de S. Joao, Porto, Portugal.
Abstract:
We treated 256 children who had identified bacterial meningitis with cefotaxime. Causative organisms were: Neisseria meningitidis in 108 cases, Streptococcus pneumoniae in 61, Haemophilus influenzae in 60, enteric Gram-negative bacilli in 21, and Staphylococcus spp. in six. Daily doses of cefotaxime were 150-200 mg/kg. A total of 240 patients (93.7%) were cured. In the cured patients, sterilization of cerebrospinal fluid was obtained in the first 72 h of treatment in 214 (80.0%). Cefotaxime is an effective and safe drug for the treatment of childhood bacterial meningitis.
Insights
Cefotaxime effectively treated bacterial meningitis in 256 children, with 93.7% cured. This antibiotic rapidly sterilized cerebrospinal fluid, proving safe and effective for childhood bacterial meningitis.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Pharmacology
Background:
- Bacterial meningitis remains a significant cause of childhood morbidity and mortality.
- Prompt and effective antibiotic therapy is crucial for favorable outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of cefotaxime in treating bacterial meningitis in children.
- To assess the impact of cefotaxime on cerebrospinal fluid sterilization.
Main Methods:
- A prospective study involving 256 children diagnosed with bacterial meningitis.
- Treatment administered with cefotaxime at daily doses of 150-200 mg/kg.
- Causative pathogens included Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, and Gram-negative bacilli.
Main Results:
- A high cure rate of 93.7% (240 out of 256 patients) was achieved.
- Cerebrospinal fluid sterilization within 72 hours was observed in 80.0% of cured patients.
- Cefotaxime demonstrated effectiveness against common bacterial meningitis pathogens in children.
Conclusions:
- Cefotaxime is a highly effective and safe therapeutic option for bacterial meningitis in pediatric populations.
- Early sterilization of cerebrospinal fluid with cefotaxime correlates with successful treatment outcomes.
- The study supports the continued use of cefotaxime in managing childhood bacterial meningitis.